This page is part of the Adverse Event Clinical Research (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
Generated Narrative: MedicationAdministration
Resource MedicationAdministration "medication-administration-tucatinib-reduced"
status: completed
Concept |
tucatinib 150 MG Oral Tablet (RxNorm#2361290) |
subject: Patient/patient-example-kaitlyn-b " BOUNCE"
occurence: 2020-05-20
performer
Actors
Reference Practitioner/practitioner-oncology-nurse-jane " NURSE"
request: MedicationRequest/medication-request-example-tucatinib
note: Patient took 1 tablet 2x daily (By Practitioner/practitioner-oncology-nurse-jane @2020-05-20)
Route | Dose |
Oral route (qualifier value) (SNOMED CT#26643006) | 250 MG (Details: UCUM code MG = 'MG') |